Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Mezagitamab, Mezagitamab placebo-matching injection administered SC
Takeda
IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also known as Berger's disease)
1 trial -
Micofenolato de mofetil Generis 250 mg Cápsulas, Inflectra 100 mg powder for concentrate for solution for infusion, Cisplatin 1 mg/ml Concentrate for Solution for Infusion, Carboplatin 10 mg/ml concentrate for solution for infusion, Gemcitabine 100 mg/ml Concentrate for Solution for Infusion, IMFINZI 50 mg/mL concentrate for solution for infusion., Oxaliplatine Accord 5 mg/ml concentraat voor oplossing voor infusie
AstraZeneca AB
Advanced Biliary Tract Cancers
1 trial -
Mimetic granules of Yiqi-Wenjing prescriptions
The First People's Hospital of Lianyungang
Chemotherapy-induced Peripheral Neuropathy
1 trial -
Mipomersen
IONIS PHARMACEUTICALS INC
Hypercholesterolemia
1 trial -
Mipomersen sodium
IONIS PHARMACEUTICALS INC
Hypercholesterolemia
1 trial -
Mirasol-treated Fresh Whole Blood
United Therapeutics Europe Ltd
Transfusion-Transmitted Infectious Disease
1 trial -
Mirena 20 mikrogram/24 timmar intrauterint inlägg, Kyleena® 19,5 mg, intrauterint inlägg, Jaydess 13,5 mg, intrauterint inlägg
The George Institute
Post medical abortion contraception
1 trial -
Mitapivat
Agios Netherlands B.V.
Non-Transfusion-dependent Alpha-Thalassemia
1 trial -
Mitapivat
Agios Netherlands B.V.
Pediatric Pyruvate Kinase Deficiency
2 trials -
Mitapivat
Agios Netherlands B.V.
Sickle Cell Disease
2 trials -
Mitapivat Matched Placebo
Agios Netherlands B.V.
Transfusion-dependent Alpha-Thalassemia
1 trial -
Mixed salts of a single-entity amphetamine
Takeda
Attention Deficit Disorder With Hyperactivity
1 trial -
Modafinil
Teva Pharma GmbH
Attention Deficit/Hyperactivity Disorder
3 trials -
Modiodal 100 mg tabletten, PLACEBO
Disc Medicine
Inflammatory bowel disease, Fatigue
1 trial -
Molnupiravir Matching placebo tablets, molnupiravir
Merck Sharp and Dohme
SARS-CoV-2 (COVID-19) infection
1 trial -
MomeGalen 1 mg/g cutaneous emulsion, Placebo to 0.1% mometasone furoate cutaneous emulsion (active ingredient-free vehicle of mometasone cutaneous emulsion), ECURAL Fettcreme, 1 mg/g Creme
Lacuna Pharma Pty Ltd
Plaque psoriasis
1 trial -
Mometasonfuroaat Teva 50 microgram/verstuiving, neusspray, suspensie, Mometasonfuroat-ratiopharm® 50 Mikrogramm/Sprühstoß Nasenspray, Suspension, Placebo for benralizumab for clinical trials is a sterile liquid solution presented in an accessorized prefilled syringe (apfs) for subcutaneous injection., Fasenra 30 mg solution for injection in pre-filled syringe
AstraZeneca AB
Severe CRSwNP patients with asthma.
1 trial -
Monalizumab, Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung, CETUXIMAB
AstraZeneca AB
Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With an Immune Checkpoint Inhibitor
1 trial -
Monofer, injektions- og infusionsvæske, opløsning
Lacuna Pharma Pty Ltd
Chronic Heart Failure
1 trial -
Motivational interviewing
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
Mounjaro 5 mg solution for injection in pre-filled pen, cagrilintide semaglutide, cagrilintide semaglutide, Mounjaro 2.5 mg solution for injection in pre-filled pen, cagrilintide semaglutide
NovoThirteen
Type 2 Diabetes
1 trial -
Moxifloxacin
BRIGHT MINDS BIOSCIENCES INC.
Tuberculosis, Pulmonary, Drug Sensitive
1 trial -
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide & Rifampicin
BRIGHT MINDS BIOSCIENCES INC.
Pulmonary Tuberculosis
1 trial -
Mycofit, 250 mg, kapsułki twarde, volrustomig, Saline, Remsima 100 mg powder for concentrate for solution for infusion
AstraZeneca AB
Locally advanced cervical cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources